Cargando…

Burden of chronic urticaria relative to psoriasis in five European countries

BACKGROUND: Quantification of burden of chronic spontaneous urticaria (CSU) vs. psoriasis (PsO) is limited. OBJECTIVE: To evaluate the burden associated with CSU vs. PsO of all severities (overall PsO), mild and moderate/severe PsO. METHODS: This retrospective cross‐sectional analysis compared data...

Descripción completa

Detalles Bibliográficos
Autores principales:	Balp, M.M., Khalil, S., Tian, H., Gabriel, S., Vietri, J., Zuberbier, T.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2017
Materias:	Allergy, Eczema and Urticaria
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6084337/ https://www.ncbi.nlm.nih.gov/pubmed/28898460 http://dx.doi.org/10.1111/jdv.14584

Ejemplares similares

A retrospective analysis omalizumab treatment patterns in patients with chronic spontaneous urticaria: a real‐world study in Belgium
por: Lapeere, H., et al.
Publicado: (2019)

Consensus on the diagnostic and therapeutic management of chronic spontaneous urticaria in adults - Brazilian Society of Dermatology
por: Criado, Paulo Ricardo, et al.
Publicado: (2019)

The current extent of and need for shared decision making in atopic dermatitis and psoriasis in the Netherlands: an online survey study amongst patients and physicians
por: van der Kraaij, G.E., et al.
Publicado: (2020)

The patient‐reported disease burden in adults with atopic dermatitis: a cross‐sectional study in Europe and Canada
por: de Bruin‐Weller, M., et al.
Publicado: (2020)

Both children and adult patients with difficult‐to‐treat atopic dermatitis have high prevalences of concomitant allergic contact dermatitis and are frequently polysensitized
por: Boonstra, M., et al.
Publicado: (2018)

Effect of immunosuppressive treatment on biomarkers in adult atopic dermatitis patients
por: Roekevisch, E., et al.
Publicado: (2020)

A phase 2, open‐label study of single‐dose dupilumab in children aged 6 months to <6 years with severe uncontrolled atopic dermatitis: pharmacokinetics, safety and efficacy
por: Paller, A.S., et al.
Publicado: (2020)

Impact of baricitinib in combination with topical steroids on atopic dermatitis symptoms, quality of life and functioning in adult patients with moderate‐to‐severe atopic dermatitis from the BREEZE‐AD7 Phase 3 randomized trial
por: Wollenberg, A., et al.
Publicado: (2021)

Impact of oral abrocitinib on signs, symptoms and quality of life among adolescents with moderate‐to‐severe atopic dermatitis: an analysis of patient‐reported outcomes
por: Cork, M.J., et al.
Publicado: (2021)

Stepwise approach of development of dermo‐cosmetic products in healthy and atopic dermatitis paediatric population: safety evaluation, clinical development and postmarket surveillance
por: Ribet, V., et al.
Publicado: (2019)

Defining and measuring ‘eczema control’: an international qualitative study to explore the views of those living with and treating atopic eczema
por: Howells, L., et al.
Publicado: (2019)

Allergen‐specific immunotherapy with apples: selected cultivars could be a promising tool for birch pollen allergy
por: Nothegger, B., et al.
Publicado: (2020)

Patient‐reported outcomes from the JADE COMPARE randomized phase 3 study of abrocitinib in adults with moderate‐to‐severe atopic dermatitis
por: Thyssen, J.P., et al.
Publicado: (2021)

Validation of the Patient‐Oriented SCORing for Atopic Dermatitis tool for black skin
por: Faye, O., et al.
Publicado: (2019)

The Impact of Chronic Urticaria from the Patient’s Perspective: A Survey in Five European Countries
por: Balp, Maria-Magdalena, et al.
Publicado: (2015)

Diagnosis of urticaria
por: Schoepke, Nicole, et al.
Publicado: (2013)

Relations between a standardized experimental stressor and cutaneous sensory function in patients with chronic pruritus and healthy controls: an experimental case–control study
por: Schneider, G., et al.
Publicado: (2018)

Emollient efficacy and acceptability in the treatment of eczematous dry skin: A double-blind, randomised comparison of two UK-marketed products
por: Djokic-Gallagher, Jasmina, et al.
Publicado: (2016)

Prurigo nodularis: a physician survey to evaluate current perceptions of its classification, clinical experience and unmet need
por: Pereira, M.P., et al.
Publicado: (2018)

The Burden of Chronic Urticaria from Brazilian Patients’ Perspective
por: Balp, Maria-Magdalena, et al.
Publicado: (2017)

Erratum to: The Burden of Chronic Urticaria from Brazilian Patients’ Perspective
por: Balp, Maria-Magdalena, et al.
Publicado: (2017)

Urticaria and mimickers of urticaria
por: Fok, Jie Shen, et al.
Publicado: (2023)

Chronic Urticaria: The Need for Improved Definition
por: Gómez, R. Maximiliano, et al.
Publicado: (2022)

Beta-lactam-induced immediate hypersensitivity reactions: A genome-wide association study of a deeply phenotyped cohort
por: Nicoletti, Paola, et al.
Publicado: (2021)

Basophils, high-affinity IgE receptors, and CCL2 in human anaphylaxis
por: Korosec, Peter, et al.
Publicado: (2017)

Use of multiple epinephrine doses in anaphylaxis: A systematic review and meta-analysis
por: Patel, Nandinee, et al.
Publicado: (2021)

Cardiovascular changes during peanut-induced allergic reactions in human subjects
por: Ruiz-Garcia, Monica, et al.
Publicado: (2021)

Comorbidities of Chronic Urticaria: A glimpse into a complex relationship
por: Papapostolou, Niki, et al.
Publicado: (2022)

Urticaria in Pregnancy and Lactation
por: Kocatürk, Emek, et al.
Publicado: (2022)

Editorial: The complexity of urticaria
por: Makris, Michael, et al.
Publicado: (2023)

Multicentric and Observational Study of Omalizumab for Chronic Spontaneous Urticaria in Real-Life in Colombia
por: García-Gómez, Elizabeth, et al.
Publicado: (2022)

Disease Impact, Diagnostic Delay, and Unmet Medical Needs of Patients With Cholinergic Urticaria in German-Speaking Countries
por: Altrichter, Sabine, et al.
Publicado: (2022)

The many faces of pediatric urticaria
por: Sekerel, Bulent Enis, et al.
Publicado: (2023)

Omalizumab Reduces Unplanned Healthcare Interactions in Irish Patients With Chronic Spontaneous Urticaria
por: Ridge, Katie, et al.
Publicado: (2021)

Navigating patients with atopic dermatitis or chronic spontaneous urticaria during the COVID-19 pandemic
por: Haddad, Isabelle, et al.
Publicado: (2022)

Efficacy and safety of omalizumab therapy in urticaria vasculitis
por: Petrelli, Fiorella, et al.
Publicado: (2022)

Acute Urticaria and Anaphylaxis: Differences and Similarities in Clinical Management
por: Ensina, Luis Felipe, et al.
Publicado: (2022)

Circulating microRNA signatures in patients with chronic Urticaria
por: Jerobin, Jayakumar, et al.
Publicado: (2023)

581 Chronic Urticaria and Infections
por: Aguilar, Nadia, et al.
Publicado: (2012)

β-arrestin-1 and β-arrestin-2 Restrain MRGPRX2-Triggered Degranulation and ERK1/2 Activation in Human Skin Mast Cells
por: Wang, Zhao, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_aqq7p4768rrgv9dpbpn5aiipii